Antenatal hormone therapy for fetal lung maturation.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 9891625)

Published in Clin Perinatol on December 01, 1998

Authors

J D Merrill1, R A Ballard

Author Affiliations

1: University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia, USA.

Articles by these authors

Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics (1999) 1.72

Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol (1995) 1.64

Risk factor analysis of intraventricular hemorrhage in low-birth-weight infants. J Pediatr (1981) 1.56

Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence. Pediatrics (1979) 1.49

Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics (1998) 1.31

Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis. Infect Immun (1994) 1.27

Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest (1975) 1.26

Fetal sex and prenatal betamethasone therapy. J Pediatr (1980) 1.17

Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics (1991) 1.13

Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol (1999) 1.11

Acquired cytomegalovirus infection in preterm infants. Am J Dis Child (1979) 1.04

Effect of medical and social risk factors on outcome of prematurity and very low birth weight. J Pediatr (1990) 0.98

Glucocorticoid receptors and the role of glucocorticoids in fetal lung development. Proc Natl Acad Sci U S A (1972) 0.97

Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics (1995) 0.93

Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. A supporting view. Am J Dis Child (1976) 0.92

Prenatal administration of betamethasone for prevention of patient ductus arteriosus. J Pediatr (1981) 0.90

Transient hyperammonemia of the preterm infant. N Engl J Med (1978) 0.90

Control of oxygenation during the transport of sick neonates. Pediatrics (1980) 0.89

Theophylline treatment in the extubation of infants weighing less than 1,250 grams: a controlled trial. Pediatrics (1987) 0.85

Corticosteroid stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung: evidence for de novo protein synthesis mediated by glucocorticoid receptors. Endocrinology (1983) 0.85

Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate. J Clin Invest (1974) 0.85

Pilot trial of late booster doses of surfactant for ventilated premature infants. J Perinatol (2011) 0.84

Identifying abnormalities in symbiotic development between Trifolium spp. and Rhizobium leguminosarum bv. trifolii leading to sub-optimal and ineffective nodule phenotypes. Ann Bot (2012) 0.84

Outcome of very low birth weight infants: multiple gestation versus singletons. Pediatrics (1994) 0.83

Corticosteroids and respiratory distress syndrome: status 1979. Pediatrics (1979) 0.82

Videophone use improves maternal interest in transported infants. Crit Care Med (1983) 0.82

Thyrotropin-releasing hormone for prevention of neonatal respiratory disease. Lancet (1995) 0.81

Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites. J Perinatol (2009) 0.81

Association of plasma cortisol and chronic lung disease in preterm infants. Pediatrics (2001) 0.81

Prenatal administration of betamethasone for prevention of respiratory distress syndrome. J Pediatr (1979) 0.81

Preliminary observations on the behavior of children present at the birth of a sibling. Pediatrics (1979) 0.80

Developmental follow-up of infants with persistent pulmonary hypertension of the newborn. Clin Perinatol (1984) 0.80

Corticosteroid binding by fetal rat and rabbit lung in organ culture. J Steroid Biochem (1984) 0.79

Idiopathic respiratory distress syndrome. Treatment with continuous negative-pressure ventilation. Am J Dis Child (1973) 0.78

Clinical use of antenatal corticosteroids: benefits and risks. Pediatr Rev (2000) 0.78

The effect of inhaled nitric oxide on pulmonary function in preterm infants. J Perinatol (2007) 0.77

Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin-releasing hormone treatment. TRH Collaborative Trial Participants. Pediatr Res (1998) 0.77

Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Pediatr Res (1992) 0.77

What pediatricians say to mothers of sick newborns: an indirect evaluation of the counseling process. Pediatrics (1979) 0.75

Glucocorticoids in prevention of respiratory distress syndrome. Hosp Pract (1980) 0.75